TEVA
LOW Impact
TEVA
Teva Pharmaceutical Reports 2024 Financial Results
|
8-K
Summary
Teva Pharmaceutical Industries Ltd. announced its financial results for the period ended December 31, 2024, as disclosed in a press release. The detailed financial information was not provided in the 8-K filing but is referenced in the attached press release, which is not available in the exhibit section.
Profitelligence Alerts
Get alerts for TEVA
Be first to know when TEVA files with the SEC.
Filing Categories
General Statement
No viable tag
Exhibits (1)
Advertisement
Official SEC Documents
TEVA Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings
Advertisement